1. Home
  2. CLDX vs KWR Comparison

CLDX vs KWR Comparison

Compare CLDX & KWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

BUY

Current Price

$31.09

Market Cap

3.0B

Sector

Health Care

ML Signal

BUY

KWR

Quaker Houghton

SELL

Current Price

$161.25

Market Cap

2.7B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
CLDX
KWR
Founded
N/A
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.7B
IPO Year
1995
1994

Fundamental Metrics

Financial Performance
Metric
CLDX
KWR
Price
$31.09
$161.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
7
Target Price
$63.07
★ $192.57
AVG Volume (30 Days)
★ 1.8M
104.1K
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
★ 1.32%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 2.68
Revenue
$12,743,000.00
★ $1,888,634,000.00
Revenue This Year
$19.74
$7.64
Revenue Next Year
$438.11
$4.50
P/E Ratio
★ N/A
$59.99
Revenue Growth
★ 87.78
2.66
52 Week Low
$22.10
$112.18
52 Week High
$45.14
$183.01

Technical Indicators

Market Signals
Indicator
CLDX
KWR
Relative Strength Index (RSI) 30.11 53.16
Support Level $28.82 $146.56
Resistance Level $31.80 $163.11
Average True Range (ATR) 2.09 3.59
MACD -0.29 0.49
Stochastic Oscillator 5.78 74.97

Price Performance

Historical Comparison
CLDX
KWR

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.

Share on Social Networks: